BAIT

TFAP4

AP-4, bHLHc41
transcription factor AP-4 (activating enhancer binding protein 4)
Homo sapiens
PREY

RELA

NFKB3, p65
v-rel avian reticuloendotheliosis viral oncogene homolog A
GO Process (43)
GO Function (20)
GO Component (5)

Gene Ontology Biological Process

Homo sapiens

Phenotypic Suppression

A genetic interaction is inferred when mutation or over expression of one gene results in suppression of any phenotype (other than lethality/growth defect) associated with mutation or over expression of another gene.

Publication

Systematic interrogation of tumor cell resistance to CAR T cell therapy in pancreatic cancer.

Hagel KR, Arafeh R, Gang S, Arnoff TE, Larson RC, Doench JG, Mathewson ND, Wucherpfennig KW, Maus MV, Hahn WC

Chimeric antigen receptor (CAR) T cell therapy can lead to dramatic clinical responses in B cell malignancies. However, early clinical trials with CAR T cell therapy in non-B cell malignancies have been disappointing to date, suggesting that tumor intrinsic features contribute to resistance. To investigate tumor intrinsic modes of resistance, we performed genome scale CRISPR-Cas9 screens in mesothelin (MSLN)-expressing pancreatic ... [more]

Cancer Res Dec. 22, 2022; (); [Pubmed: 36548402]

Throughput

  • Low Throughput

Ontology Terms

  • phenotype: viability (PATO:0000169)

Additional Notes

  • CRISPR method
  • depletion of p65 ablated the effect of TFAP4 depletion to enhance tumor cell survival in the presence of CAR T cells

Curated By

  • BioGRID